Head of Research Group at the Institute of Social and Preventive Medicine at the University of Bern (Switzerland). Christian Althaus uses mathematical and computational modeling in combination with data analyses to investigate how the population biology of infectious diseases is affected by environmental changes, dynamic patterns of host immunity, or public health interventions. Key areas of his research are the transmission and control of sexually transmitted infections (STI), antimicrobial resistance and emerging infectious diseases.
Associate Professor in the Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine.
Stefan Baral is a physician epidemiologist and an Associate Professor in the Department of Epidemiology at the Johns Hopkins School of Public Health (JHSPH). Stefan has led epidemiological studies among key populations including men who have sex with men and sex workers in Southern, Eastern, and Western African countries as well as in Central and Southeastern Asia. Stefan acts as the Director of the Key Populations Program for the Center for Public Health and Human Rights at the JHSPH.
Keith A. Crandall, PhD is the Founding Director of the Computational Biology Institute at George Washington University. Professor Crandall studies the computational biology, population genetics, and bioinformatics, developing and testing of methods for DNA sequence analysis. He applies such methods to the study of the evolution of both infectious diseases (especially microbiome diversity) and crustaceans (especially decapod crustaceans). Professor Crandall has published over 300 peer reviewed publications, as well as three books. He has been a Fulbright Visiting Scholar to Oxford University and an Allen Wilson Centre Sabbatical Fellow at the University of Auckland. Professor Crandall has received a number of awards for research and teaching, including the American Naturalist Society Young Investigator Award, an NSF CAREER Award, a PhRMA Foundation Faculty Development Award in Bioinformatics, Honors Professor of the Year award at Brigham Young University, ISI Highly Cited Researcher, and the Edward O. Wilson Naturalist Award. He is also an elected Fellow in the American Association for the Advancement of Science (AAAS) and a Fellow of the Linnean Society of London. Professor Crandall earned his BA degree from Kalamazoo College in Biology and Mathematics, an MA degree from Washington University in Statistics, and a PhD from Washington University School of Medicine in Biology and Biomedical Sciences. He also served as a Peace Corps Volunteer in Puyo, Ecuador.
Josh is a clinician researcher, and divides his time between clinical work as an Infectious Diseases physician in Newcastle, and research work as a principal research fellow based at Menzies.
He completed his clinical infectious diseases training in 2004, and then worked on a PhD from 2007-2010 on the epidemiology, pathophysiology and adjunctive treatment of sepsis in the Top End of the Northern Territory (NT).
His main clinical interests are general infectious diseases, viral hepatitis, hepatology, HIV infection, refugee health and infections in the critical care setting. His main research interests are clinical trials in the management of severe infections and epidemiology of severe bacterial infections.
Josh is the vice president of the Australasian Society for Infectious Diseases (ASID) and is also the deputy chair of the ASID clinical research network. In 2015, Josh was awarded a prestigious career development fellowship from the NHMRC and also a $1 million project grant to conduct a randomised controlled trial investigating the use of combination antibiotic therapy for MRSA blood stream infection (the CAMERA study).
Director of the National AIDS Center, Istituto Superiore di Sanità, Rome, Italy. Co-Vice President and Member of the Presidential Committee of the AIDS National Commission, Ministry of Health. Member of the European Molecular Biology Organisation (EMBO).
Reader in Pathogen Dynamics at the University of Cambridge; formerly Adjunct Associate Professor in the Dept. of Pathology, University of California San Diego (UCSD). Graduated with a BA in Natural Sciences (1st class), Trinity College, Cambridge (1992), DPhil in Mathematical Biology, Merton College, Oxford (1996). Postdoctoral positions at Princeton University, Oxford University, University of Edinburgh and UCSD. Awards include: NATO Postdoctoral Fellowship (1996), MRC Nonclinical Training Fellowship (1997-2000), a Royal Society Wolfson Research Merit Award (2008-2013), and Thomson-Reuters Highly Cited Researcher awards in 2014, 2015, and 2016.
Dr. Gao is a Professor and Director of the Cancer Virology Program at the Hillman Cancer Center and in the Department of Microbiology and Molecular Genetics in the University of Pittsburgh School of Medicine.
Dr. Gao is an Elected Fellow of the American Academy of Microbiology. He currently serves as the Editor-In-Chief for the Journal of Medical Virology, Section Editor for PLoS Pathogens, and Academic Editor for PLoS One and PeerJ. He is also serving on the Editorial Boards of over 10 peer-reviewed journals including Journal of Virology, Journal of Antivirals & Antiretrovirals, Journal of Molecular Biomarkers and Diagnosis, Journal of Microbial & Biochemical Technology, Sarcoma Research International, Oncolytic Virotherapy, etc.
Delia Goletti MD, PhD, Infectious Diseases specialist. In 1992 she joined the Laboratory of Immunoregulation at the National Institutes of Health (chief Dr Fauci) working on HIV pathogenesis. In 1999 she joined the National Institute for Infectious Diseases in Rome. She has clinical duties on the tuberculosis (TB) clinic and responsibility of the Translational Research Unit where she works on TB pathogenesis, TB immunodiagnostic tests and impact of Heminths infection on HIV and TB disease.
Senior Lecturer in Communicable Disease Epidemiology, School of Public Health, University of Sydney; Public Health Lead and Node Leader for Mass Gathering Medicine, Marie Bashir Institute, University of Sydney; Honorary Life Fellow, St Andrew's College within the University of Sydney; Senior Member and College Research Associate, Wolfson College, University of Cambridge
I studied medicine in Cambridge and during my junior doctor years was very interested in both neurology and infectious diseases. Clinically I specialised in medical microbiology, keeping a particular interest in neurological infections. For the past 3 years I have been in Saudi Arabia developing a pathogen genomics laboratory where I have gained first-hand experience of second generation sequencing and bioinformatics.
Infectious diseases and medical microbiology are undergoing the most significant shift since PCR was introduced. By the end of this decade, sequencing will have become the main option when investigating any outbreak or infection. I study the interface between genomics as a pure science and its translation into clinical and public health benefits.
At present I am examining the worldwide genomics of tuberculosis, the use of sequencing to characterise MRSA strains and the genomic variations in BCG vaccine strains used around the globe.
PhD = cloning and characterizing potential vaccine antigens from schistosomes; first postdoc = fine details of HIV replication (with David Harrich); second postdoc = best ignored; third postdoc = role of Max network, especially Mnt, in cancer and development (with Peter Hurlin). After that I made HIV POC tests and other diagnostic devices in two small biotech companies. Now I'm a research manager with Canon US Life Sci.
Professor Leondios Kostrikis is a Professor at University of Cyprus. He received his B.Sc. and Ph.D. degrees from New York University and his post-doctoral training at the Aaron Diamond AIDS Research Center of Rockefeller University. He joined the Rockefeller University as an Assistant Professor in 1999 and the University of Cyprus as Professor in 2003. He was a Fulbright, Elizabeth Glazer Pediatric AIDS Foundation and Aaron Diamond Foundation scholar. He has directed over twenty competitive grants from the NIH and the European Commission and he is an Editorial Board member for eleven international journals.